871979-07-6

Basic information

• Product Name: 5-[(1-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinyl)carbonylamino]levulinic acid methyl ester
• Synonyms: 5-[(1-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinyl)carbonylamino]levulinic acid methyl ester
• CAS NO: 871979-07-6
• Molecular Weight: 406.436
• Mol File: 871979-07-6.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-[(1-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinyl)carbonylamino]levulinic acid methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 5-[(1-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinyl)carbonylamino]levulinic acid methyl ester(871979-07-6)
• EPA Substance Registry System: 5-[(1-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinyl)carbonylamino]levulinic acid methyl ester(871979-07-6)

Safety Data

• Hazardous Substances Data: 871979-07-6(Hazardous Substances Data)

Upstream product

• 79416-27-6 methyl aminolevulinate 
• 75176-20-4 N-(benzyloxycarbonyl)-cis-4-methoxy-L-proline 
• 13504-86-4 (2S,4S)-1-benzyloxycarbonyl-4-hydroxyproline 
• 75176-19-1 N-<(phenylmethoxy)carbonyl>-4(S)-methoxy-(S)-proline methyl ester 

Downstream Products

• 871979-10-1 3-[2-[1-[2,5-dichloro-4-(1-methyl-3-indolylcarbonylamino)phenylacetyl]-(4S)-methoxy-(2S)-pyrrolidinyl]-5-oxazolyl]propionic acid methyl ester 
• 871979-08-7 3-[2-(1-benzyloxycarbonyl-(4S)-methoxy-(2S)-pyrrolidinyl)-5-oxazolyl]propionic acid methyl ester 

Relevant articles and documents

VLA-4 INHIBITOR

An object of the present invention is to provide a compound which selectively inhibits binding of a ligand and ±421 integrin (VLA-4), a process for producing the compound, and a medicament containing the compound. A compound represented by the formula (I) etc. orasaltthereof, a process for producing the compound or a salt thereof, a medicament containing the compound or a salt thereof, as well as a preventive and/or a therapeutic agent for a disease caused by cell adhesion, for example, inflammatory reaction, autoimmune disease, cancer metastasis, bronchial asthma, nasal obstruction, diabetes, arthritis, psoriasis, multiple sclerosis, inflammatory bowel disease and rejection reaction at transplantation, containing the compound or a salt thereof as a primary component. [wherein Y 1 represents a divalent aryl group etc. , V 1 represents an aryl group etc., and R 11 to R 14 represent H, OH or a halogen atom etc.]